INFORMAZIONI SU QUESTO ARTICOLO

Cita

1. Bura M. et al.: Seroprevalence of hepatis A virus antibodies (anti- HAV) in adult inhabitants of Wielkopolska region, Poland - the role of Simple demographic factors. Ann. Agric. Environ. Med., 19, 738-741, 2012.Search in Google Scholar

2. Centers for Disease Control and Prevention: prevention of hepatitis A though active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR, Recomm. Rep., 48, 1-37, 1999.Search in Google Scholar

3. Chiroma M., et al.: Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination. Infect. Dis., 12, 271, 1471-2334, 2012.10.1186/1471-2334-12-271352732723098290Search in Google Scholar

4. Faillon S. et al.: Impact of travel on the seroprevalence of hepatitis A in children. J. Clin. Virol., 56, 46-51, 2013.10.1016/j.jcv.2012.10.00423127561Search in Google Scholar

5. Jacobsen K.H., Koopman J.S.: Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol. Infect., 132, 1005-1022, 2004.10.1017/S0950268804002857Search in Google Scholar

6. Janaszek-Seydlitz W., Bucholc B., Wiatrzyk A.: Poziom przeciwciał przeciwko wirusowemu zapaleniu wątroby typu A u osób z terenu Warszawy. Przegl. Epidemiol., 61, 675-682, 2007.Search in Google Scholar

7. Klevens R.M. et al.: Seroprevalence of Hepatitis A Virus Antibodies in the US: Results from the National Health and Nutrition Examination Surgey. Public Health Reports, 126, 522-32, 2011.10.1177/003335491112600408311521121800746Search in Google Scholar

8. Knowles N.J. et al: Picornaviridae. [In:] King A.M.R., Adams MJ, Carstens EB, Lefkowitz EJ (editors) Virus taxonomy: classification and nomenclature of viruses: ninth report of the international committee on taxonomy of viruses. Elsevier, San Diego, pp 855-880, 2012Search in Google Scholar

9. Krumbholz A. et al.: Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany. Med. Microbiol.Immunol., doi 10.1007/s00430-013-0303-4Search in Google Scholar

10. Kurkela S. et al.: Comparative hepatitis A seroepidemiology in 10 European countries. Epidemiol. Infect., 140, 2172-2181, 2012,doi:10.1017/S0950268812000015.10.1017/S095026881200001522273572Search in Google Scholar

11. Lee H.C. et al.: Changing epidemiological patterns of hepatitis A infection in Singapore. Ann. Acad. Med. Singapore, 40, 439-447, 2011.Search in Google Scholar

12. MacDonald E.et al.: Increase in hepatitis A in tourists from Denmark, England, Germany, the Netherlands, Norway and Sweden returning from Egypt, November 2012 to March 2013. Euro Surveill., 18, pii=20468, 2013.10.2807/ese.18.17.20468-enSearch in Google Scholar

13. Polz-Dacewicz M., Policzkiewicz P., Badach Z.: Changing epidemiology of hepatitis A virus infection - a comparative study in Central Eastern Poland (1990-1999). Med Sci Monit 6, 989-993, 2000.Search in Google Scholar

14. Van Herck K., Jacquet J.M., Van Damme P.: Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years. J. Med. Virol., 83, 1885-91, 2011, doi: 10.1002/jmv.22200.10.1002/jmv.2220021915861Search in Google Scholar

15. Whelan J. et al.: Evaluation of hepatitis a vaccine in post-exposure prophylaxis, the Netherlands, 2004-2012. PLoS One., 17;8; e:78914, 2013, doi: 10.1371/journal.pone.0078914.10.1371/journal.pone.0078914379829924147144Search in Google Scholar

eISSN:
2300-6676
ISSN:
2084-980X
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy